Tomorrow Night on Today Tonight WA



Just got off the phone from Monika Kos. She rang me on the customer service line, and yes, I am the one who looks after it. Thank goodness most of you are using the website, twitter and facebook except if I possibly can it is always good to talk to people.

We had a bit of a Q & A session and a good talk. She was a very patient listener. There is so much I want to get out to people yet the world of media is a world of only seconds and minutes if you are lucky. Very appreciative of the time she gave.

It will be running tomorrow night at 6.30 pm.

She said she was interested in the product for herself! (I hope you do not mind me mentioning that Monika – you will see why I mention this below).

Yes, I have heard of professional sports people and people who put their body under physical stress using it as a prophylactic (preventative). In most cases I do not know why or how Condrosulf users are using Condrosulf except I am aware that it is being used by some people who participate in high levels of sporting activity.

Except the main thing to remember here is that if a presenter on a current affairs program from a national television network takes a Condrosulf subscription – well ladies and gentlemen – I think you can be rest assured that there will be a high level of accountability to make sure everything runs smoothly!


Did you like this? Share it:

Last Night on Today Tonight SA – a tiny flash of light.


Hello everyone and welcome.

Many of you would have seen the media last night.

The video will be posted on the Today Tonight SA site in a few days. So for those of you who missed it please keep checking.

The very brief exposure gave people only a tiny glimpse of the whole story behind Condrosulf. It is an epic tale spanning decades. It involves global institutions, battles with big pharma, some won, some lost, a disturbing proximity to the biggest medical journal scandal so far this century and some say in modern medical publishing history, yet even so the full story still remains, uninvestigated and untold.

Except all you need to know at this point in time is that Condrosulf has survived, it exists, it is safe and Australia is the first English speaking country in the world with access to it’s own supply.

In amongst all that has happened over the decades Condrosulf’s highly advanced Swiss pharmaceutical manufacturing and research has kept steadily working away and leading the world from its Swiss mountain hideaway.

A few trial results later and enter a cast of 1000’s of colorfully packaged, sports celebrity endorsed wannabe health supplements who wish they were Condrosulf and quite simply, by sheer weight of numbers, completely bury Condrosulf from public view. Condrosulf’s medical literature is shamelessly and repeatedly borrowed, yet when you put your glasses on and read the fine print you will often discover the medical trial they claim for the science behind their ‘joint health’ products is actually Condrosulf’s literature. Even though the manufacturing standard of the health supplement product bears no resemblance whatsoever to Condrosulf’s medical standards of manufacture. Certainly the world’s leading specialists in this area have that opinion, except unless you keep the world’s leading medical journals on your side table for a bit of light bed time reading you will never know about this.

Condrosulf is the product that was actually in the trials. Real, credible medical trials published in real, credible medical journals. The ones that your rheumatologist actually reads, or ought to, if they had the time. Sometimes, some of them do.

Enter big pharma with literally an army of either ‘well presented’ (aka very good looking) or ‘personable’ (funny and likable), or perhaps both, very well paid pharmaceutical reps. Drilled by the companies that earn the billions, these are the foot soldiers that keep your GP, healthcare professional and rheumatologist on page, with reams of extremely glossy brochures and every ridiculous knick knack you can think of with a logo and the brand of the latest pill. Anyone for a bubble pen? They were so popular amongst the nursing staff people still sigh wistfully with their passing. Tried one out once – I have to admit is was fun.

Condrosulf has never had a bubble pen, a sports celebrity endorsement and in Australia, no army of reps kicking down your doctor’s door – so, if you want to find out what on earth I am talking about, what on earth Condrosulf is, I am sorry, you are going to have get a cup of tea, put your glasses on and sit down and read.

That’s enough for now. More to follow.

Please check back.

If you are a Twitterite or a Facebooker please like/subscribe and you can get the early notice on the latest post and be the first one with the good oil and the latest chapter on the story of a product that ought to have been in Australia certainly 20, perhaps even 30 years ago.

Just how can that happen?!

To be perfectly honest, I am not entirely sure – my answers really are only the best ones I can put together from nearly 20 years in the game and the best facts I can get my hands on.

If anyone reads my posts and they have something they think I ought to know – I am all ears.

Every group needs someone who can read. They are very important to their friends and family who may not.

Please be that person.

Did you like this? Share it:

Most Condrosulf subscribers become long term customers

Condrosulf is an exceptional product operating in a market dominated by brands that have much room for improvement. If only Condrosulf’s commitment to medical research was matched by more manufacturers in the chondroitin industry.

Condrosulf holds up a lantern in the dark storm of confusion that is the non-prescription joint health sector. Condrosulf is often hard to see and hard to find. Yet when stumbled upon, or finally discovered after some earnest research, Condrosulf offers an improvement in quality of life much valued by those who form a relationship with it.

Condrosulf was first registered as a medical grade chondroitin sulfate in 1982. That is 31 years now and predates any other chondroitin joint health health supplement/nutraceutical, let alone medical product by almost two decades. Condrosulf is almost completely alone when it comes to medical grade chondroitin products.

It is completely and totally on its own if you consider the evidence from a large body of peer reviewed published medical literature with numerous RCTs (Randomly Controlled Trials) to be a necessary accompanient to therapeutic claims. The shark derived Condrosulf that is supplied by this website has a long history in research on knee, hip, hand and finger joints. It was 15 years ago its particular affinity for finger and hand arthritis came to the fore. Thus prompting further clinical trials specifically in this area.

While the Swiss origin shark derived Condrosulf has been demonstrated in clinical trials to be effective in significantly retarding the progression of arthritis in joints other than the hands and fingers it is difficult not to be excited by the “FACTS Hand and Finger’  trial results that became widely available to the public in November 2012.

In the excitement it is easy to forget that this is in fact the third such Condrosulf trial in this area. While Condrosulf first caught my attention in 1996, 17 years ago, I was busy working on other projects in the chondroitin sulfate industry until in 2007. While I was not short for opportunities, I simply could no longer ignore what IBSA had achieved with Condrosulf and CS Ethical Pty Ltd was incorporated 6 years ago to make Condrosulf available to Australians and many other countries in the world via this website.

When the website was first developed it was an experimental addition to a very standard Australian pharmaceutical wholesaling company. Yet consumers and in particular the very determined group of long term subscribers whose constant and valuable contributions to the development of the website shaped its evolution. Since the latest Condrosulf trial results on fingers and hands became available traffic to the website has trebled in the recent past and continues to steadily grow.

It appears the English speaking world is finally and slowly beginning to discover a highly credible and extremely academic quiet achiever that has worked steadily for decades producing a product of exceptional quality for European health systems and patients. Condrosulf and its Swiss manufacturer IBSA are traditionally a very conservative product and institution. It is really only the lightning fast development of technology and e-commerce that has enabled Condrosulf to migrate beyond its traditional habitat of European national health systems out into the wider world.

A recent review of our Condrosulf subscribers revealed that most people who try a Condrosulf subscription become long term subscribers.

It seems Condrosulf subscribers choose their company carefully.

Did you like this? Share it:

Please contribute to the discussion & benefit yourself & others

One individual’s thoughtful question can benefit so many others.

Up until now I have answered many enquiries on a one on one basis. However I strongly encourage enquirers to write up their questions in the comments box below the posts and then the question and the answer can benefit others, hundreds, perhaps even thousands of times over.

All comments go via a moderator to ensure it is not spam, offensive or repetitive. So your comment may take a day or two to come up so please be patient and check back in later.

If you asked a question and you would like even more information than was provided in the initial answer, please ask away again. Am happy to expand the depth of the answer if people are interested.

So please, contribute your questions to the comments box and the answers can benefit many others, many times over – worldwide.

Did you like this? Share it:

Condrosulf Medical Literature Available

Condrosulf has a large body of peer reviewed published literature to support its claims to efficacy.

Medical literature is available for distribution from Condrosulf Australia to health professionals in any English speaking country.

Condrosulf medical literature is technical in nature and it would require appropriate qualifications in a relevant healthcare discipline for it to be of value to its recipient.

It can be distributed via electronic means or hard copies sent by mail upon the receipt of a request and a determination that the request is a bona fide enquiry.

If health professionals could please also provide the name of their place of practice, teaching institution or a reference to a publication they have contributed to. All details will be kept in confidence and are only required in order to validate the request.

The Condrosulf Description is international material that provides healthcare professionals a useful summary of Condrosulf’s characteristics.  This material was authored for use in countries where Condrosulf is already available through national health systems.

In an Australian regulatory context this material is only suitable for medical professionals. It is not suitable for use as promotional literature to Australian consumers.

While Condrosulf, in an international context, is frequently referred to as a prescription product, in Australia it has been determined to have a safety profile that does not require medical supervision.


Did you like this? Share it:

New Website

Happy New Year and a big first ‘social media’ Hello! to all the fellow Australians who over the last few years have had the rather exclusive privilege of being the first and pioneering users of Condrosulf in Australia.

It seems really quite remarkable that it took nearly 30 years for Condrosulf to get to Australia – yet good things are worth waiting for.

Yes we are currently out of stock except that shall be remedied in the very near future. I’ll let you all know the moment it is available.

As for now  may I invite you to explore this ‘new style’ of website. May I say I am genuinely excited about the idea of developing it into a valuable resource for the Australian Condrosulf community.

Andrew Mowbray

Managing Director

Did you like this? Share it: